erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
lea ament, left, and tamara nunley talk about the care their team provided for helen and robert valenzuela at st. jude medical center in fullerton. (scott smeltzer / staff photographer)
.
.
.
.
from around the web
.
.
the financial times and its journalism are subject to a self-regulation regime under the ft editorial code of practice:
https://grassfed.us/Sizer-mother-of-Acampora-from-Puriscal